Provide a valuable resource to your clients or customers by linking to this resource page. Just place the following link on your website.
Eye lymphoma, particularly primary vitreoretinal lymphoma, is a rare non-Hodgkin B-cell lymphoma that affects the retina, vitreous and optic nerve. It often occurs in both eyes and may be associated with lymphoma in the brain. People with weakened immune systems or certain genetic changes have a higher risk. Early detection is challenging because symptoms mimic inflammation, but prompt treatment is essential.
read more about eye lymphoma ...Ocular lymphoma develops when lymphocytes become malignant and accumulate in eye tissues. The exact cause is unknown, but risk factors include immunosuppression, older age and genetic mutations. Primary vitreoretinal lymphoma is linked to central nervous system lymphoma, so evaluation for brain involvement is important.
Symptoms may include blurred or decreased vision, floaters, red or swollen eyes, sensitivity to light and occasionally eye pain. Because the disease often affects both eyes and mimics inflammatory conditions, diagnosis can be delayed. Persistent or unexplained changes in vision warrant evaluation.
Diagnosis involves a comprehensive eye exam, imaging and a vitrectomy to obtain vitreous fluid for biopsy. Brain imaging is often done to check for central nervous system involvement. Early detection improves outcomes, but ocular lymphoma can recur even after treatment, so ongoing monitoring is necessary.
Treatment usually includes chemotherapy injected into the eye or administered systemically, and external radiation therapy. Targeted therapy or immunotherapy may be added. Managing ocular and central nervous system disease together provides the best chance for remission. Regular follow-up exams help detect recurrence.
Outcomes vary. With chemotherapy and radiation, many patients achieve remission, but the disease can recur. Early diagnosis and combined treatment improve prognosis.
People with weakened immune systems, older adults and those with certain genetic changes have a higher risk. Eye lymphoma is rare but should be considered in persistent inflammatory eye conditions.
Diagnosis often requires a vitrectomy to obtain fluid for biopsy, along with imaging studies of the eye and brain. A specialist will interpret results to determine if malignant lymphocytes are present.
Chemotherapy and radiation may cause cataracts, dry eye, retinal damage or systemic side effects. Your oncology team will discuss risks and benefits and monitor you closely during therapy.